Cite Filings / AMLX / 0001193125-26-033641

Feed Companies Filings Check

Sign in

144

Sale of Securities

Amylyx Pharmaceuticals, Inc. Filed 2026-02-02 Acc 0001193125-26-033641

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2026-02-23 144 Sale of Securities
2026-02-04 4 Chief Legal Officer sold 3,448 shares at $14.65 ($50,516)
2026-02-04 4 Co-Chief Executive Officer sold 15,500 shares at $14.69 ($227,618)
2026-02-02 144 Sale of Securities
2026-02-02 144 Sale of Securities
2026-02-02 144 Sale of Securities
2026-02-02 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…